Company NeoGenomics, Inc.

Equities

NEO

US64049M2098

Healthcare Facilities & Services

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Ratings for NeoGenomics, Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical & Diagnostic Laboratories

Real-time Estimate Cboe BZX Other stock markets 02:02:16 2024-04-23 pm EDT			5-day change	1st Jan Change
14.33 ^USD	+6.78%		+3.07%	-11.77%

Apr. 18	NeoGenomics, Inc. Announces Senior Leadership Promotions	CI
Apr. 18	NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics	CI

NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.

Number of employees: 2,100

USD in Million	2022	Weight	2023	Weight	Delta
Clinical Services 83.8 %	419	82.2 %	496	83.8 %	+18.36%
Advanced Diagnostics 16.2 %	91	17.8 %	96	16.2 %	+5.53%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	510	100.0 %	592	100.0 %	+16.07%

Managers	Title	Age	Since
Chris Smith CEO	Chief Executive Officer	61	22-08-14
Lynn Tetrault CHM	Chairman	61	15-06-11
Jeffrey Sherman DFI	Director of Finance/CFO	58	22-12-06
Derek Lyle CTO	Chief Tech/Sci/R&D Officer	-	21-06-30
Shashikant Kulkarni CTO	Chief Tech/Sci/R&D Officer	57	22-03-06
Greg Sparks CTO	Chief Tech/Sci/R&D Officer	56	-
Hutan Hashemi CMP	Compliance Officer	45	22-02-28
Forrest Holmes Blocker CTO	Chief Tech/Sci/R&D Officer	-	-
Melody Harris COO	Chief Operating Officer	58	22-12-04
Steven Ross CTO	Chief Tech/Sci/R&D Officer	60	13-04-21

Members of the board	Title	Age	Since
Bruce Crowther BRD	Director/Board Member	72	14-10-21
Michael Kelly BRD	Director/Board Member	67	20-07-14
Chris Smith CEO	Chief Executive Officer	61	22-08-14
David B. Perez BRD	Director/Board Member	64	22-11-02
Anthony Zook BRD	Director/Board Member	63	23-06-25
Lynn Tetrault CHM	Chairman	61	15-06-11
Stephen M. Kanovsky BRD	Director/Board Member	61	17-07-18
Alison Hannah BRD	Director/Board Member	63	15-06-11
Neil Gunn BRD	Director/Board Member	-	23-06-25
Elizabeth Floegel BRD	Director/Board Member	-	23-06-25

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	127,665,638	126,162,754 ( 98.82 %)	0	98.82 %

Name	Equities	%	Valuation
BlackRock Advisors LLC 15.02 %	19,162,502	15.02 %	301 M $
Vanguard Fiduciary Trust Co. 11.10 %	14,169,665	11.10 %	223 M $
Brown Investment Advisory & Trust Co. 7.557 %	9,643,599	7.557 %	152 M $
T. Rowe Price Investment Management, Inc. 5.002 %	6,382,515	5.002 %	100 M $
Janus Henderson Investors US LLC 4.975 %	6,348,613	4.975 %	100 M $
STATE STREET CORPORATION 3.797 %	4,844,945	3.797 %	76 M $
Greenhouse Funds LLLP 3.396 %	4,333,031	3.396 %	68 M $
Macquarie Investment Management Business Trust 3.198 %	4,081,179	3.198 %	64 M $
First Light Asset Management LLC 3.077 %	3,926,756	3.077 %	62 M $
Dimensional Fund Advisors LP 2.356 %	3,006,523	2.356 %	47 M $

NeoGenomics, Inc.

9490 NeoGenomics Way

33912, Fort Myers

http://www.neogenomics.com

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

13.42 USD

Average target price

21.1 USD

Spread / Average Target

+57.23%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
NEOGENOMICS, INC.	-17.06%	1.71B
SONIC HEALTHCARE LIMITED	-16.30%	8.18B
RADNET, INC.	+37.04%	3.51B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-28.32%	2.9B
SYNLAB AG	-7.53%	2.47B
DR. LAL PATHLABS LIMITED	-12.81%	2.25B
FLEURY S.A.	-22.34%	1.47B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-39.86%	1.22B
ADICON HOLDINGS LIMITED	-10.74%	1.09B
METROPOLIS HEALTHCARE LIMITED	+6.64%	1.1B

Medical & Diagnostic Laboratories